Male Sexual Health Questionnaire (MSHQ) - Sexual Function Study

Inclusion Criteria: * Patients suffering from moderate to severe lower urinary tract symptoms (LUTS), suggestive of symptomatic Benign Prostatic Hyperplasia (BPH) diagnosed by the Investigator * Patients with an I-PSS total score ≥ 8 * Patients sexually active as defined by at least one of the following activities in the last 4 weeks: intercourse, caressing, foreplay, masturbation Exclusion Criteria: * Patients with a known history of hepatic or severe renal insufficiency, unstable angina pectoris * Patients who had a previous prostate surgery * Patients who had a prostate biopsy or minimally invasive procedure within 6 months prior to inclusion * Patients with a prostate surgery or minimally invasive procedure during the whole study period * Patients with an active urinary tract infection or prostatitis * Patients with a neuropathic bladder defined as a spinal injury consequence or related to a neurological disorder or a known residual volume ≥ 350 ml * Patients with a diagnosed prostate cancer * Patients having received 5a-reductase inhibitors or LUTS related-phytotherapy within 6 months prior to inclusion, or a1-blockers within 30 days prior to inclusion * Patients receiving any treatment for erectile dysfunction (i.e. phosphodiesterase-5 inhibitors) at inclusion * Patients with a history of postural hypotension or syncope * Patients with a known hypersensitivity to alfuzosin The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.